Earlier in 2020, PharmaBoardroom sat down with several key stakeholders in the Mexican healthcare and life sciences industry, from the leaders of…

David López García, Mexico country manager of global rare genetic therapy player Biomarin, outlines the challenging situation around patient access…

James Lennertz, Group VP and GM EUMEA for BioMarin, discusses the key highlights of the past few years for BioMarin, their unique positioning as a…